Samoa Digital Library
Blocking Coronavirus 19 Infection via the SARS-CoV‑2 Spike Protein: Initial Steps
- Samoa Digital Library
- →
- National University of Samoa
- →
- Journal Articles
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Whisenant, Jonathan | |
| dc.contributor.author | Burgess, Kevin | |
| dc.date.accessioned | 2020-11-26T02:40:16Z | |
| dc.date.available | 2020-11-26T02:40:16Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | ACS Med. Chem. Lett. 2020, 11, 1076−1078 | en_US |
| dc.identifier.uri | ${sadil.baseUrl}/handle/123456789/136 | |
| dc.description | 3 p. | en_US |
| dc.description.abstract | Recent crystal structure data for protein−protein interactions featuring the SARS-CoV-2 spike protein will inevitably trigger a new wave of research in this area that was not possible before. This Viewpoint outlines a few of the ways that it is already happening. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | ACS Medicinal Chemistry Letters | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | spike protein | en_US |
| dc.subject | peptide | en_US |
| dc.subject | monoclonal antibody | en_US |
| dc.title | Blocking Coronavirus 19 Infection via the SARS-CoV‑2 Spike Protein: Initial Steps | en_US |
| dc.type | Article | en_US |
